Top 30 Stocks to Buy in 2026: Re-Ranking Top Stocks by Valuation
A sector-adjusted Price-to-Sales deep dive into market capitalization vs. trailing revenues.
The standard list of popular growth stocks often conflates "best companies" with "best valuations to buy now." To fix this, we re-ranked 30 major market leaders through a strict valuation lens: Current Market Capitalization ÷ Trailing Twelve Month (TTM) Revenue (P/S), adjusted for sector context.
The Revised 30-Stock Valuation Ranking
Rank #1 represents the most heavily premium-priced stock relative to revenue, while Rank #30 represents the cheapest.
| Rank | Stock | Market Cap | TTM Revenue | P/S Multiple | Valuation Zone |
|---|---|---|---|---|---|
| 1 | Palantir (PLTR) | $414.6B | $5.22B | 79.4× | 🔴 Extremely Overvalued |
| 2 | Arm Holdings (ARM) | ~$258B | $5.16B | 50.0× | 🔴 Extremely Overvalued |
| 3 | Broadcom (AVGO) | $1.87T | $75.46B | 24.7× | 🔴 Very Overvalued |
| 4 | AMD (AMD) | $826B | $37.45B | 22.1× | 🔴 Very Overvalued |
| 5 | Nvidia (NVDA) | $5.42T | $253.5B | 21.4× | 🔴 Very Overvalued |
| 6 | Seagate (STX) | $225.8B | ~$12.2B | 18.5× | 🔴 Overvalued |
| 7 | TSMC (TSM) | $2.24T | $121.9B | 18.3× | 🔴 Overvalued |
| 8 | ASML (ASML) | $723B | $41.0B | 17.6× | 🟠 Overvalued |
| 9 | Western Digital (WDC) | $184.8B | $11.77B | 15.7× | 🟠 Overvalued |
| 10 | Visa (V) | $670B | $43.0B | 15.6× | 🟠 Overvalued |
| 11 | Eli Lilly (LLY) | $1.05T | $72.24B | 14.6× | 🟠 High |
| 12 | Mastercard (MA) | $493B | $33.93B | 14.5× | 🟠 High |
| 13 | Micron (MU) | $1.14T | $90.27B | 12.7× | 🟡 Upper-Middle |
| 14 | Microsoft (MSFT) | $3.57T | $318.3B | 11.2× | 🟡 Upper-Middle |
| 15 | Apple (AAPL) | $4.46T | $451.4B | 9.9× | 🟡 Middle/High |
| 16 | Alphabet (GOOGL) | $4.18T | $422.5B | 9.9× | 🟡 Middle/High |
| 17 | Meta (META) | $1.45T | $215.0B | 6.7× | 🟢 Reasonable |
| 18 | NextEra Energy (NEE) | $179.8B | $27.86B | 6.5× | 🟢 Reasonable |
| 19 | Oracle (ORCL) | $422B | $67.35B | 6.3× | 🟢 Reasonable |
| 20 | Johnson & Johnson (JNJ) | ~$618B | $97.9B | 6.3× | 🟢 Reasonable |
| 21 | Coca-Cola (KO) | $374B | $49.28B | 7.6× | 🟢 Reasonable/High |
| 22 | JPMorgan (JPM) | ~$950B | $186.3B | 5.1× | 🟢 Reasonable |
| 23 | Samsung Electronics | $1.30T | $270.9B | 4.8× | 🟢 Reasonable/Cheap |
| 24 | Procter & Gamble (PG) | ~$341B | $87.0B | 3.9× | 🟢 Reasonable/Cheap |
| 25 | Amazon (AMZN) | $2.82T | $742.8B | 3.8× | 🟢 Reasonable |
| 26 | Qualcomm (QCOM) | $170B | $44.48B | 3.8× | 🟢 Undervalued |
| 27 | Novo Nordisk (NVO) | $196.6B | $51.37B | 3.8× | 🟢 Undervalued |
| 28 | Intel (INTC) | ~$108B | $53.1B | 2.0× | 🟢 Deep Value / Turnaround |
| 29 | Berkshire Hathaway (BRK.B) | $1.07T | $385.7B | 2.8× | 🟢 Cheap on Sales |
| 30 | Sinopharm (1099.HK) | $6.7B | $82.2B | 0.08× | 🟢 Extremely Cheap |
Key Insights & Valuation Takeaways
Intel's positioning on this chart highlights the core difference between pure sales-based valuation and market expectations for semiconductor execution.
1. Semiconductor Valuation Dispersion
The gap across semiconductor players is staggering: Broadcom (24.7×), AMD (22.1×), and Nvidia (21.4×) trade at massive growth premiums, whereas fab and hardware giants like Qualcomm (3.8×) and Intel (2.0×) provide significantly higher revenue coverage per dollar invested.
2. Premium AI Leaders vs. Fundamental Delivery
Palantir (79.4× P/S) and Arm Holdings (50.0× P/S) require continuous hyper-growth and flawless margin execution. Meanwhile, Nvidia's high 21.4× multiple is anchored by massive fundamental scale, generating over $253B in trailing revenues.
Framework: Risk-Adjusted Valuation Tiers
Qualcomm, Novo Nordisk, Samsung, Amazon, Alphabet, Microsoft, Meta, JPMorgan.
These companies balance robust cash-flow moats with reasonable sales multiples.
Intel, Sinopharm, Berkshire Hathaway.
Assets trading at low revenue multiples where re-rating depends on structural recovery or capital deployment.
Palantir, Arm Holdings, Seagate, Western Digital.
High growth potential offset by historical cyclicality or sky-high current multiples.
Related: Top 30 Stocks to Buy and Hold in 2026: Best AI, Technology, Healthcare and Global Blue-Chip Stocks
.png)







Comments